Toxins · 2018 · 24 citations · 56 references
Life SciencesBiochemistryBiotechnologyBioseparationsNeuroimmunologyProtein EngineeringBacterial ToxinsEnzyme PurificationProtein PurificationToxin ProductionBotulinum NeurotoxinBotulinum ToxinsProtein Toxins
We have purified and characterized recombinant botulinum neurotoxin serotype FA (BoNT/FA). This protein has also been named as a new serotype (serotype H), but the classification has been controversial. A lack of well-characterized, highly pure material has been a roadblock to study. Here we report purification and characterization of enzymatically active, and of inactive nontoxic, recombinant forms of BoNT/FA as tractable alternatives to purifying this neurotoxin from native Clostridium botulinum. BoNT/FA cleaves the same intracellular target proteins as BoNT/F1 and other F serotype BoNTs; the intracellular targets are vesicle associated membrane proteins (VAMP) 1, 2 and 3. BoNT/FA cleaves the same site in VAMP-2 as BoNT/F5, which is different from the cleavage site of other F serotype BoNTs. BoNT/FA has slower enzyme kinetics than BoNT/F1 in a cell-free protease assay and is less potent at inhibiting ex vivo nerve-stimulated skeletal muscle contraction. In contrast, BoNT/FA is more potent at inhibiting neurotransmitter release from cultured neurons.
56
SV2 Is the Protein Receptor for Botulinum Neurotoxin A
Min Dong, Felix L. Yeh, William H. Tepp et al. · Science · 2006 · 771 citations
Molecular Characterization of a Novel Botulinum Neurotoxin Type H Gene
Nir Dover, Jason R. Barash, Karen K. Hill et al. · The Journal of Infectious Diseases · 2013 · 280 citations